CAS: 1204707-71-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | SRT3109 REF: AN-AG008TJPCAS: 1204707-71-0 | 98+% | 611.00 €~1,371.00 € | Wed 08 May 24 |
 | SRT3109 REF: TM-T3047CAS: 1204707-71-0 | 99.92% | 129.00 €~1,188.00 € | Wed 15 May 24 |
 | AZD 5069 REF: 3D-FD41314CAS: 1204707-71-0 | Min. 95% | 174.00 €~458.00 € | Tue 21 May 24 |
SRT3109
CAS:1204707-71-0
Formula:
C18H23F2N5O4S2
Purity:
98+%
Color and Shape:
Solid
Molecular weight:
475.5331
Ref: AN-AG008TJP
| 50mg | 611.00 € | |
| 100mg | 915.00 € | |
| 250mg | 1,371.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
SRT3109
CAS:1204707-71-0
SRT3109 is a CXCR2 ligand used in the treatment of chemokine mediated diseases and conditions.
Formula:
C18H23F2N5O4S2
Purity:
99.92%
Color and Shape:
Solid
Molecular weight:
475.53
Ref: TM-T3047
| 1mg | 129.00 € | |
| 2mg | 173.00 € | |
| 5mg | 263.00 € | |
| 10mg | 395.00 € | |
| 25mg | 639.00 € | |
| 50mg | 889.00 € | |
| 100mg | 1,188.00 € | |
| 1ml*10 (DMSO) | 275.00 € |
Estimated delivery in United States, on Wednesday 15 May 2024
AZD 5069
CAS:1204707-71-0
CXCR2 antagonist
Formula:
C18H23F2N5O4S2
Purity:
Min. 95%
Color and Shape:
White To Off-White Solid
Molecular weight:
475.11595
Ref: 3D-FD41314
| 10mg | 174.00 € | |
| 50mg | 458.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
